Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (191-200 of 218) with videos related to

Pageof 22
Sort By:
Cancer Treatment Reports|November 1, 1982
Phase II trial of mitoxantrone in advanced colorectal cancerE M Bonnem, E P Mitchell, P V Woolley, et al.
Cancer|October 1, 1979
A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinomaP V Woolley, J S MacDonald, T Smythe, et al.
Cancer|November 15, 1984
A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancerR M Silgals, J D Ahlgren, J R Neefe, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Gastroenterology|July 1, 1977
Gastrointestinal involvement in the Sézary syndromeM I Cohen, L W Widerlite, G P Schechter, et al.
Annals of Internal Medicine|July 1, 1975
Peritoneoscopy: a valuable staging tool in ovarian carcinomaS H Rosenoff, R C Young, T Anderson, et al.
Gynecologic Oncology|January 1, 1985
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancerJ G Posada, A B Marantz, K Y Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusionS Korec, P S Schein, F P Smith, et al.
Cancer|November 1, 1980
5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasF P Smith, D F Hoth, B Levin, et al.
Cancer Treatment Reports|October 1, 1976
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parametersL R Morgan, P S Schein, P V Woolley, et al.
Pageof 22

Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Cancer Treatment Reports|November 1, 1982
Phase II trial of mitoxantrone in advanced colorectal cancerE M Bonnem, E P Mitchell, P V Woolley, et al.
Cancer|October 1, 1979
A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinomaP V Woolley, J S MacDonald, T Smythe, et al.
Cancer|November 15, 1984
A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancerR M Silgals, J D Ahlgren, J R Neefe, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Gastroenterology|July 1, 1977
Gastrointestinal involvement in the Sézary syndromeM I Cohen, L W Widerlite, G P Schechter, et al.
Annals of Internal Medicine|July 1, 1975
Peritoneoscopy: a valuable staging tool in ovarian carcinomaS H Rosenoff, R C Young, T Anderson, et al.
Gynecologic Oncology|January 1, 1985
The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancerJ G Posada, A B Marantz, K Y Yeung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusionS Korec, P S Schein, F P Smith, et al.
Cancer|November 1, 1980
5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasF P Smith, D F Hoth, B Levin, et al.
Cancer Treatment Reports|October 1, 1976
Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parametersL R Morgan, P S Schein, P V Woolley, et al.
Pageof 22